To test whether TZD treatment improves insulin sensitivity in mice with partial lipodystrophy, PpargC/- mice and wild-type mice were fed an HFD supplemented with rosiglitazone (HFDTZD) for 4 weeks. This evidence concerns the gene INS and lipodystrophy.